A previous successful application of biomarkers in cancer treatments was found in which patients with tumors that had both PIK3CA mutation and PTGS2 expression respond best to aspirin therapy.39 Additional research would be required to confirm our findings. The gene discussed is PIK3CA; the disease is cancer.